Lavipharm
Vaggelis Siozios is an experienced R&D Scientist currently employed at Lavipharm since June 2023. Prior to this role, Vaggelis served as a Formulation Lab Assistant at Lamda Laboratories from May 2021 to May 2023. Additional experience includes working as a Pharmacist at a Local Pharmacy from July 2020 to May 2021 and completing multiple internships at Local Pharmacies and the General Hospital of Athens "Alexandra" between 2017 and 2018. Vaggelis holds a Bachelor of Pharmacy (BPharm) in Pharmaceutics and Drug Design from the National Kapodistrian University of Athens and is currently pursuing a Master’s degree in Health Economics and Management at the University of Piraeus since October 2023.
This person is not in any offices
Lavipharm
1 followers
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. It is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.